LITERATURE SUMMARIES, ASSESSMENTS, FOR BEST PHARMACEUTICALS FOR CHILDREN ACT

受美国国立卫生研究院委托，NICHD负责实施国会授权的2002年儿童最佳药品法案，该法案于2007年重新授权。NICHD负责优先的、非专利的、用于儿童但缺乏足够儿科标签的药物的临床试验。人口与发展中心的责任包括行政活动和支助，以及协调支助和其他国际组织参与BPCA活动。本项目的功能是为BPCA提供文献总结、评估和元分析。用于进行儿童药理学研究的数据。

The NICHD, as delegated by the NIH, is responsible for implementing the Congressionally-mandated Best Pharmaceuticals for Children Act of 2002, as reauthorized in 2007. The NICHD is responsible for the performance of clinical trials of priority, ¿off patent¿ drugs that are used in children but that lack sufficient pediatric labeling. NICHD responsibility includes administrative activities as well as support, and coordinating support and participation of other ICs in BPCA activities. The function of this project is to provide literature summaries, assessments, and meta-analysis for the BPCA. Data used to conduct pharmacology studies in children.